NVCR Insider Transactions — Page 2
951 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Shah Pritesh | Chief Growth Officer | 2023-03-03 | Sale | 2,942.0 | $76.16 |
| Shah Pritesh | Chief Growth Officer | 2023-03-03 | Sale | 1,570.0 | $76.16 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-03 | Sale | 20,415.0 | $76.16 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-03 | Sale | 1,692.0 | $76.16 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-03 | Sale | 3,528.0 | $76.16 |
| Cordova Ashley | Chief Financial Officer | 2023-03-03 | Sale | 775.0 | $76.16 |
| Cordova Ashley | Chief Financial Officer | 2023-03-03 | Sale | 4,730.0 | $76.16 |
| Burke William Patrick | Chief Human Resources Officer | 2023-03-03 | Sale | 593.0 | $76.16 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-03 | Sale | 2,059.0 | $77.64 |
| Burke William Patrick | Chief Human Resources Officer | 2023-03-02 | Sale | 281.0 | $75.28 |
| Shah Pritesh | Chief Growth Officer | 2023-03-02 | Sale | 937.0 | $75.28 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-02 | Sale | 1,213.0 | $75.28 |
| Cordova Ashley | Chief Financial Officer | 2023-03-02 | Sale | 1,055.0 | $75.28 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sale | 844.0 | $75.28 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sale | 308.0 | $76.05 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-02 | Sale | 3,799.0 | $75.32 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-01 | Sale | 1,684.0 | $76.36 |
| Shah Pritesh | Chief Growth Officer | 2023-03-01 | Sale | 1,923.0 | $76.36 |
| Cordova Ashley | Chief Financial Officer | 2023-03-01 | Sale | 2,198.0 | $76.36 |
| Burke William Patrick | Chief Human Resources Officer | 2023-03-01 | Sale | 755.0 | $76.36 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-03-01 | Sale | 2,164.0 | $76.36 |
| Weinberg Uri | Chief Science Officer | 2023-01-05 | Sale | 1,201.0 | $120.0 |
| Weinberg Uri | Chief Science Officer | 2023-01-05 | Sale | 2,617.0 | $108.0 |
| Weinberg Uri | Chief Science Officer | 2023-01-05 | Sale | 1,946.0 | $120.0 |
| Weinberg Uri | Chief Science Officer | 2023-01-05 | Sale | 2,379.0 | $120.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 7,183.0 | $120.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 7,183.0 | $114.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 5,517.0 | $108.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 7,500.0 | $108.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 7,826.0 | $108.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 1,010.0 | $117.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 526.0 | $115.03 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 417.0 | $108.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-01-05 | Sale | 2,345.0 | $119.01 |
| Shah Pritesh | Chief Commercial Officer | 2023-01-05 | Sale | 387.0 | $108.0 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 187,500.0 | $108.0 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 500.0 | $119.99 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 1,344.0 | $119.35 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 2,123.0 | $118.47 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 999.0 | $117.01 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 1,395.0 | $116.06 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 3,702.0 | $115.21 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 4,568.0 | $114.35 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 2,000.0 | $112.86 |
| Danziger Asaf | Chief Executive Officer | 2023-01-05 | Sale | 8,369.0 | $111.23 |
| Leonard Frank X | President, CNS Cancers US | 2022-10-13 | Sale | 6,754.0 | $76.01 |
| Leonard Frank X | President, CNS Cancers US | 2022-10-06 | Sale | 6,754.0 | $84.37 |
| Leonard Frank X | President, CNS Cancers US | 2022-09-29 | Sale | 6,754.0 | $77.35 |
| Leonard Frank X | President, CNS Cancers US | 2022-09-22 | Sale | 6,754.0 | $77.0 |
| Leonard Frank X | Chief Development Officer | 2022-09-15 | Sale | 5,517.0 | $90.0 |
| Leonard Frank X | Chief Development Officer | 2022-09-15 | Sale | 6,754.0 | $87.31 |
| Leonard Frank X | Chief Development Officer | 2022-09-09 | Sale | 1,863.0 | $88.0 |
| Leonard Frank X | Chief Development Officer | 2022-09-08 | Sale | 6,754.0 | $81.48 |
| Leonard Frank X | Chief Development Officer | 2022-09-06 | Sale | 1,384.0 | $78.57 |
| Burke William Patrick | Chief Human Resources Officer | 2022-09-02 | Sale | 718.0 | $79.04 |
| Cordova Ashley | Chief Financial Officer | 2022-09-02 | Sale | 885.0 | $79.04 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2022-09-02 | Sale | 296.0 | $79.04 |
| Shah Pritesh | Chief Commercial Officer | 2022-09-02 | Sale | 269.0 | $79.04 |
| Leonard Frank X | Chief Development Officer | 2022-09-02 | Sale | 584.0 | $79.04 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 48.0 | $78.96 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 438.0 | $78.14 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 360.0 | $77.06 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 240.0 | $75.88 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 1,088.0 | $78.68 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 2,720.0 | $77.92 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 1,750.0 | $76.96 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 1,200.0 | $75.93 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 452.0 | $78.66 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 2,955.0 | $78.09 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 1,914.0 | $77.0 |
| Leonard Frank X | Chief Development Officer | 2022-09-01 | Sale | 1,047.0 | $75.94 |
| Benaim Ely | Chief Medical Officer | 2022-08-03 | Sale | 5,396.0 | $74.0 |
| Benaim Ely | Chief Medical Officer | 2022-08-03 | Sale | 563.0 | $71.09 |
| DOYLE WILLIAM F | Executive Chairman | 2022-08-02 | Sale | 837.0 | $69.66 |
| Benaim Ely | Chief Medical Officer | 2022-08-02 | Sale | 437.0 | $69.66 |
| Leonard Frank X | Chief Development Officer | 2022-08-02 | Sale | 414.0 | $69.66 |
| HILLEMAN JERYL L | Director | 2022-06-10 | Sale | 407.0 | $69.61 |
| Benaim Ely | Chief Medical Officer | 2022-05-11 | Sale | 2,135.0 | $61.25 |
| Benaim Ely | Chief Medical Officer | 2022-05-10 | Sale | 2,070.0 | $65.16 |
| Shah Pritesh | Chief Commercial Officer | 2022-03-09 | Sale | 3,669.0 | $71.19 |
| Shah Pritesh | Chief Commercial Officer | 2022-03-08 | Sale | 2,481.0 | $70.1 |
| Leonard Frank X | Chief Development Officer | 2022-03-08 | Sale | 744.0 | $70.1 |
| Burke William Patrick | Chief Human Resources Officer | 2022-03-08 | Sale | 1,037.0 | $70.1 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2022-03-08 | Sale | 2,923.0 | $70.1 |
| Cordova Ashley | Chief Financial Officer | 2022-03-08 | Sale | 759.0 | $70.1 |
| Longsworth Todd Christopher | General Counsel | 2022-03-08 | Sale | 2,339.0 | $70.1 |
| DOYLE WILLIAM F | Executive Chairman | 2022-03-08 | Sale | 2,385.0 | $70.1 |
| Shah Pritesh | Chief Commercial Officer | 2022-03-07 | Sale | 5,294.0 | $69.55 |
| Longsworth Todd Christopher | General Counsel | 2022-03-04 | Sale | 1,973.0 | $70.41 |
| Cordova Ashley | Chief Financial Officer | 2022-03-04 | Sale | 556.0 | $70.41 |
| Shah Pritesh | Chief Commercial Officer | 2022-03-04 | Sale | 1,914.0 | $70.41 |
| Shah Pritesh | Chief Commercial Officer | 2022-03-04 | Sale | 2,632.0 | $73.34 |
| Benaim Ely | Chief Medical Officer | 2022-03-04 | Sale | 1,510.0 | $70.41 |
| Burke William Patrick | Chief Human Resources Officer | 2022-03-04 | Sale | 1,026.0 | $70.41 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2022-03-04 | Sale | 2,569.0 | $70.41 |
| Leonard Frank X | Chief Development Officer | 2022-03-04 | Sale | 555.0 | $70.41 |
| Longsworth Todd Christopher | General Counsel | 2022-03-03 | Sale | 1,094.0 | $74.5 |
| Cordova Ashley | Chief Financial Officer | 2022-03-03 | Sale | 1,149.0 | $74.5 |
| Shah Pritesh | Chief Commercial Officer | 2022-03-03 | Sale | 997.0 | $74.5 |
| Benaim Ely | Chief Medical Officer | 2022-03-03 | Sale | 803.0 | $74.5 |